Kadmon IPO Info
Company Name: Kadmon
Stock Symbol: KDMN
Exchange: NYSE
Status: Priced
IPO Date: 7/27/2016
IPO Price:
12.00 (
-55.42%)
Underwriters
Citigroup and Jefferies LLC
Amount of Offering: N/A
Number of Shares Offered: 6.25 Mil
Shares Outstanding After Offering: N/A
Valuation: N/A
Company Description
Kadmon is a fully integrated biopharmaceutical company engaged in the discovery, development and commercialization of small molecules and biologics to address disease areas of significant unmet medical need. Kadmon is developing product candidates within autoimmune and fibrotic diseases, oncology and genetic diseases.
News Headlines
